Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...

In this chapter we preview the recursive methods of analysis to be developed in detail in the rest of the book. This material falls into three broad parts, and the remainder of the book is structured ...

From shimmering and embossed covers to boatloads of bonus features, it’s hard to beat the prestige of owning a physical Blu-ray copy of your favorite films – and that’s before considering the image ...

In a study published in Nature Communications, researchers at Karolinska Institutet have mapped key steps in the assembly of the mitochondrial ribosome, offering new clues to how defects in this ...

On Friday, Claude Code creator Boris Cherny made an appearance at Meta’s @Scale conference and, surprisingly, the first question from the audience was about loops. “Are loops the next hype cycle,” the ...

Rachel Williams has been an editor for nearly two decades. She has spent the last five years working on small business content to help entrepreneurs start and grow their businesses. She’s well-versed ...

Independent registered investment advisors, or RIAs, that manage clients with investable assets of $25 million or more in the United States were eligible for this year's list. CNBC solicited ...

In a study published in Nature Communications, researchers at Karolinska Institutet have mapped key steps in the assembly of the mitochondrial ribosome, offering new clues to how defects in this ...